help button home button Endocrine Society JCEM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a related Letter to the Editor
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Schulz, A.
Right arrow Articles by Schöneberg, T.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Schulz, A.
Right arrow Articles by Schöneberg, T.
Right arrowPubmed/NCBI databases
*OMIM
*Compound via MeSH
*Substance via MeSH
Medline Plus Health Information
*Antibiotics
Hazardous Substances DB
*GENTAMYCIN
The Journal of Clinical Endocrinology & Metabolism Vol. 87, No. 11 5247-5257
Copyright © 2002 by The Endocrine Society


Original Article

Aminoglycoside Pretreatment Partially Restores the Function of Truncated V2 Vasopressin Receptors Found in Patients with Nephrogenic Diabetes Insipidus

Angela Schulz, Katrin Sangkuhl, Thomas Lennert, Marianne Wigger, David Anthony Price, Anja Nuuja, Annette Grüters, Günter Schultz and Torsten Schöneberg

Institut für Pharmakologie (A.S., K.S., G.S., T.S.), Freie Universität Berlin, Universitätsklinikum Benjamin Franklin, 14195 Berlin, Germany; Kinderklinik und Poliklinik (T.L.), Universitätsklinikum Benjamin Franklin, 12200 Berlin, Germany; Kinder- und Jugendklinik (M.W.), Medizinische Fakultät Universität Rostock, 18055 Rostock, Germany; Royal Manchester Children’s Hospital (D.A.P.), Pendlebury, Manchester M27 4HA, United Kingdom; Department of Paediatrics (A.N.), Central Hospital of Central Finland, 40620 Jyväskylä, Finland; and Klinik und Poliklinik für Kinderheilkunde (A.G.), Virchow-Klinikum, Medizinische Fakultät der Humboldt Universität zu Berlin, 13353 Berlin, Germany

Address all correspondence and requests for reprints to: Torsten Schöneberg, Institut für Pharmakologie, Freie Universität Berlin, Thielallee 69-73, 14195 Berlin, Germany. E-mail: schoberg{at}zedat.fu-berlin.de.

Abstract

By screening patients with X-linked nephrogenic diabetes insipidus (NDI) for mutations within the V2 vasopressin receptor (AVPR2) gene, we have identified six novel and two recurrent mutations. Additionally, one patient revealed a genomic deletion of 3.2 kb encompassing most of the AVPR2 gene and the last exon/3'-region of C1 gene, which is in close proximity to the AVPR2 locus. In-depth characterization of the mutant AVPR2s by a combination of functional and immunological techniques allowed to gain further insight into molecular mechanisms leading to the receptor dysfunction. Aiming at the functional reconstitution of mutant G protein-coupled receptors, several strategies of potential therapeutic usefulness have been tested. Because the functional rescue of truncated receptors is most challenging, we addressed this issue by applying an aminoglycoside approach. Here, we demonstrate that the misreading capacity of the aminoglycoside antibiotic geneticin was sufficient to restore function of mutant AVPR2s harboring premature stop codons in an in vitro expression system.




This article has been cited by other articles:


Home page
Proc. Natl. Acad. Sci. USAHome page
C. Yang, J. Feng, W. Song, J. Wang, B. Tsai, Y. Zhang, W. A. Scaringe, K. A. Hill, P. Margaritis, K. A. High, et al.
A mouse model for nonsense mutation bypass therapy shows a dramatic multiday response to geneticin
PNAS, September 25, 2007; 104(39): 15394 - 15399.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Renal Physiol.Home page
J. H. Robben, N. V. A. M. Knoers, and P. M. T. Deen
Cell biological aspects of the vasopressin type-2 receptor and aquaporin 2 water channel in nephrogenic diabetes insipidus.
Am J Physiol Renal Physiol, August 1, 2006; 291(2): F257 - F270.
[Abstract] [Full Text] [PDF]


Home page
Nephrol Dial TransplantHome page
M. Zaki, T. Schoneberg, T. Al Ajrawi, A. N. Al Said, K. Sangkuhl, and H. Rompler
Nephrogenic diabetes insipidus, thiazide treatment and renal cell carcinoma
Nephrol. Dial. Transplant., April 1, 2006; 21(4): 1082 - 1086.
[Full Text] [PDF]


Home page
J. Biol. Chem.Home page
D. E. Handy, G. Hang, J. Scolaro, N. Metes, N. Razaq, Y. Yang, and J. Loscalzo
Aminoglycosides Decrease Glutathione Peroxidase-1 Activity by Interfering with Selenocysteine Incorporation
J. Biol. Chem., February 10, 2006; 281(6): 3382 - 3388.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
C.-H. Lai, H. H. Chun, S. A. Nahas, M. Mitui, K. M. Gamo, L. Du, and R. A. Gatti
Correction of ATM gene function by aminoglycoside-induced read-through of premature termination codons
PNAS, November 2, 2004; 101(44): 15676 - 15681.
[Abstract] [Full Text] [PDF]


Home page
Hum Mol GenetHome page
K. Sangkuhl, A. Schulz, H. Rompler, J. Yun, J. Wess, and T. Schoneberg
Aminoglycoside-mediated rescue of a disease-causing nonsense mutation in the V2 vasopressin receptor gene in vitro and in vivo
Hum. Mol. Genet., May 1, 2004; 13(9): 893 - 903.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 2002 by The Endocrine Society